Lobe Sciences Ltd.
🇨🇦Canada
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Evaluation of Safety, Rate and Extent of Absorption of Psilocin Mucate
- First Posted Date
- 2023-09-13
- Last Posted Date
- 2023-09-13
- Lead Sponsor
- Lobe Sciences Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT06035900
- Locations
- 🇯🇴
Pharmaceutical Research Unit, Amman, Jordan
News
Lobe Sciences Secures European Patent Protection for DHA-Based Sickle Cell Disease Treatment
Lobe Sciences has obtained European Unitary Patent EP4117446 validation, providing intellectual property protection across 17 EU member states for its DHA and egg yolk-based composition targeting Sickle Cell Disease.